Abstract

There is a budding need to develop a method for environmentally benign metal nanoparticle synthesis, that do not use toxic chemicals in the synthesis protocols to avoid adverse effects in medical applications. The present investigation dealt with the synthesis of copper oxide (CuO) nanoparticles from blue green alga, Spirulina platensis. The algal extract consisting of phytochemicals was used as the reducing agent and copper sulphate as the substrate. Synthesised nanoparticles were characterized by UV-Vis spectrophotometry, FT-IR spectroscopy, XRD and SEM. Antibacterial and anticancer activities were assessed for the CuO nanoparticles. The results indicated that the formed CuO nanoparticles were observed to be nanosheets. FT-IR spectral analysis elucidated the occurrence of biomolecules required for the reduction of copper oxide ions. The synthesized nanoparticles were found to be effective at the concentration of 1 mg/mL against Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa and Serratia marcescens. The cytotoxicity activity of CuO nanoparticle was evaluated by MTT Assay against colon cancer cell lines and confirmed that CuO nanoparticle at a concentration of 125 µg/mL had cytotoxic activity. In conclusion, the CuO nanoparticles were synthesized at a low energy supply, in an ecologically safe mode which could be utilized for pharmacological applications and various biotechnological studies.

Highlights

  • Inflammation is the reaction of living tissues to injury, infection or irritation

  • Lysosomal enzymes released during inflammation produce a variety of disorders which leads to the tissue injury by damaging the macromolecules and lipid peroxidation of membranes which are assumed to be responsible for certain pathological conditions as heart attacks, septic shocks, and rheumatoid arthritis etc

  • human red blood cell membrane (HRBC) or erythrocyte membrane is analogous to the lysosomal membrane and its stabilization implies that the extract may as well stabilize lysosomal membranes

Read more

Summary

Introduction

Inflammation is the reaction of living tissues to injury, infection or irritation. Lysosomal enzymes released during inflammation produce a variety of disorders which leads to the tissue injury by damaging the macromolecules and lipid peroxidation of membranes which are assumed to be responsible for certain pathological conditions as heart attacks, septic shocks, and rheumatoid arthritis etc. Stabilization of lysosomal membrane is important in limiting the inflammatory response by inhibiting the release of lysosomal constituents of activated neutrophil such as bactericidal enzymes and proteases, which cause further tissue inflammation and damage upon extra cellular release or by stabilizing the lysosomal membrane (Vadivu and Lakshmi, 2008). Stabilization of human red blood cell membrane (HRBC) by hypotonicity induced membrane lysis can be taken as an in-vitro measure of anti-inflammatory activity of the drugs or plant extracts. Stabilization of human red blood cell membrane (HRBC) by hypotonicity induced membrane lysis can be taken as an in-vitro measure of anti-inflammatory activity of the drugs or plant extracts. (Sree Kumara et al, 2015)

Methods
Findings
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.